Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

Prostate

Volumn 47, Issue 4, 2001, Pages 293-303

  Dorai, Thambi ^a,c   Cao, Yi Chen ^b   Dorai, Bhuvaneswari ^a   Buttyan, Ralph ^a   Katz, Aaron E ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^c OUR LADY OF MERCY MEDICAL CENTER   (United States)

Author keywords

Alternative medicine; Angiogenesis; Apoptosis; Curcumin; Prostate cancer

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CURCUMIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CURCUMIN; GROWTH INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035370750     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1074     Document Type: Article

References (55)

1. Top 5 cancers for females and males in the U.S.
2. Epidemiology and natural history of prostate cancer
3. The biology of hormone refractory prostate cancer: Why does it develop?
4. Alternative therapies for advanced prostate cancer. What should I tell my patients?
5. Trends in alternative medicine use in the United States, 1990-1997. Results of a follow-up national survey
6. Clinical and biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
7. Decreased growth of established human prostate LNCaP tumors in nude mice fed with a low fat diet
8. Diet and its preventive role in prostatic disease
9. Effects of PC-SPES in prostate cancer patients. A preliminary investigation in human cancer cell lines and patients
10. Why drinking green tea could prevent cancer
11. Treatment of early recurrent prostate cancer with 1,25 dihydroxy vitamin D3
12. S-Allylmercaptocysteine inhibits cell proliferation and reduces cell viability of erythroleukemia, breast and prostate cancer cell lines
13. The role of soy products in reducing the risk of cancer
14. Cancer Statistics 1997
15. Geographic pathology of latent prostatic carcinoma
16. Certain aspects of molecular endocrinology that relate to the influence of dietary factors on the pathogenesis of prostate cancer
17. Pharmacology of Curcuma Longa
18. Chemistry of curcumin and curcuminoids
19. Pharmacology of diferuloylmethane (curcumin) - A nonsteroidal anti-inflammatory agent
20. Therapeutic potential of curcumin in human prostate cancer I. Curcumin induces apoptosis in both androgen dependent and androgen independent prostate cancer cells
21. Therapeutic potential of curcumin in human prostate cancer II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein
22. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
23. Treatment of progressive metastatic prostate cancer
24. Management of the cancer of the prostate
25. Complete androgen blockade for prostate cancer. What went wrong?
26. Inhibitory effect of curcumin on tumor initiation by benzo (a) pyrene and 7,12 dimethylbenz(a) anthracene
27. Inhibitory effect of curcumin, chlorogenic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate
28. Inhibitory effect of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice
29. Modulation of apoptosis by sulindac, curcumin, phenyl-3-methyl caffeate and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer prevention
30. Inhibitory effect of curcumin on epidermal growth factor receptor tyrosine kinase activity in A431 cells
31. Curcumin inhibits the tyrosine kinase activity of p185neu and also depletes p185neul
32. Chemical development plan: Curcumin. Report of the chemoprevention branch and agent development committee of NCI
33. Tumor angiogenesis correlates with metastasis in invasive prostate cancer
34. Role of VEGF-FLT receptor system in normal and tumor angiogenesis
35. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
36. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
37. Curcumin is an in vivo inhibitor of angiogenesis
38. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin
39. Curcumin, an anti-oxidant and antitumor promoter induces apoptosis in human leukemia cells
40. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates
41. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells
42. Activation of transcription factor NF-κB is suppresses by curcumin (diferuloyl methane)
43. Curcumin induces a p53 dependent apoptosis in human basal cell carcinoma cells
44. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
45. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers
46. Inhibition of lipoxygenase-1 by phosphatidylcholine micelles bound curcumin
47. Human plasma distribution of free paclitaxel and paclitaxel associated with diblock coplymers
48. Polymeric micellar paclitaxel phosphorylates bcl-2 and induces apoptotic regression of androgen independent LNCaP prostate tumors
49. Effect of epidermal growth factor on prostate cancer cell line PC-3 growth and invasion
50. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF-receptor mediated signals
51. Etk/Bmx, a tyrosine kinase with a plekstrin-homology domain, is an effector of phosphatidyl-inositol-3-kinase and is involved in IL-6 induced neuroendocrine differentiation of prostate cancer cells
52. Derivation of androgen independent human LNCaP prostatic cancer sublines: Role of bone stromal cells
53. Establishment of human prostate carcinoma skeletal metastasis models
54. LNCaP progression model of human prostate cancer: Androgen independence and osseous metastasis